用伯氏疏螺旋体lp54基因编码的重组蛋白免疫小鼠不能提供针对蜱传感染性攻击的保护
研究测试了伯氏疏螺旋体外表面膜蛋白BBA65、BBA66、BBA69、BBA70和BBA73能否预防伯氏疏螺旋体感染。小鼠单独或联合接种这些重组蛋白,在初次接种和加强注射后经蜱叮咬攻击前确认血清阳转。尽管小鼠对各抗原均有高抗体滴度,但未观察到对攻击感染的显著保护。
要点
- 小鼠接种BBA65、BBA66、BBA69、BBA70和BBA73重组蛋白后产生高抗体滴度。
- 尽管抗体滴度高,经蜱叮咬攻击后未观察到显著保护。
- 这些重组蛋白无保护作用,反映莱姆病新型疫苗候选物鉴定的困难。
核心结论
- 这些重组蛋白无保护作用,反映鉴定莱姆病有效新型疫苗候选物所面临的挑战。
研究设计与样本
- 小鼠经单独或联合接种BBA65、BBA66、BBA69、BBA70和BBA73重组蛋白,经初次接种和加强注射后确认血清阳转,再以蜱叮咬进行伯氏疏螺旋体攻击感染。
主要发现
- 尽管小鼠对各抗原均有高抗体滴度,但未观察到对攻击感染的显著保护。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The Borrelia burgdorferi outer surface membrane proteins BBA65, BBA66, BBA69, BBA70, and BBA73 were tested for their ability to confer protection against B. burgdorferi infection challenge. Mice were immunized with recombinant forms of the proteins singly or in combinations. Following initial protein inoculation and booster injections, seroconversion was confirmed prior to B. burgdorferi challenge by tick bite. Despite mice having high antibody titers for each antigen, no significant protections against the challenge infections were observed. These results demonstrate that these recombinant proteins were not protective and reflects the challenges confronted to identify effective novel vaccine candidates for Lyme disease.
引用
- Brandt KS, Gilmore RD. Immunization of mice with Borrelia burgdorferi lp54 gene encoded recombinant proteins does not provide protection against tick transmitted infectious challenge. Vaccine. 2017. PMID: 28867507. doi:10.1016/j.vaccine.2017.08.054
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。